UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $78,000 | – | 13,400 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $8,237,000 | 9.91% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,738,000 | 2.40% |
| Founders Fund V Management, LLC | 491,751 | $2,577,000 | 0.66% |
| ALGERT GLOBAL LLC | 51,890 | $272,000 | 0.08% |
| Arbor Wealth Management, LLC | 25,888 | $136,000 | 0.05% |
| Moloney Securities Asset Management, LLC | 41,950 | $220,000 | 0.05% |
| PDT Partners, LLC | 78,800 | $413,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,957 | $2,070,000 | 0.02% |
| Fort Point Capital Partners LLC | 10,000 | $52,000 | 0.01% |
| Baillie Gifford | 3,803,014 | $19,928,000 | 0.01% |